31results about How to "Practical therapeutic activity" patented technology

The invention relates to a cytisine derivative maleate or its pharmaceutically acceptable solvate and an application of the cytisine derivative maleate or its pharmaceutically acceptable solvate in preparation of medicines for treating tumors.

The invention relates to applications of fumarate of dehydrocheilanthifoline and derivatives thereof or pharmacology-acceptable solvate of the fumarate of dehydrocheilanthifoline and derivatives thereof on preparation of drugs for curing hepatitis B virus infection.

The invention relates to N-(4-((4-(3-(3-tert-butyl-1-p-methylphenyl-1H-pyrazole-5-yl) ureido) naphthalene-1-base oxygen) methyl) pyridine-2-yl)-2-methoxy acetamide and fumarate of a derivative thereof or a solvate thereof acceptable in pharmacology and an application for preparing a medicine for treating and/or relieving and/or preventing influenza.

The invention relates to fumarates of conimine derivatives or pharmaceutically acceptable solvates of the fumarates, and their use in preparation of an acetylcholinesterase inhibition drug.

The invention relates to fumarate or pharmacological acceptable solvates of dihydrosanguinarine and derivatives of the dihydrosanguinarine as well as an application of the fumarate or pharmacological acceptable solvates to the preparation of drugs for treating hepatitis B.

The invention relates to cyclopropane-carboxylic acid {3-[6-(3-(trifluoromethyl)-phenylamino)-pyrimidine-4-yl-amino]-phenyl}-amide and a derivative fumarate or a pharmaceutically acceptable solvate thereof, and an application thereof in preparation of medicines for treating cancers.

The invention relates to fumarate or pharmaceutically acceptable solvate of oxodehydrocaaverine (7-oxodehydrocavverine) and a derivative thereof, and application of oxodehydrocaaverine in preparation of a methicillin-resistant staphylococcus aureus medicine.

The invention relates to (-)sukhodianine, a fumarate of a (-)sukhodianine derivative, or a pharmacologically acceptable solvate of the fumarate, and applications of the pharmacologically acceptable solvate in preparation of drugs used for controlling methicillin-resistant staphylococcus aureus.

The invention relates to fumarate or pharmaceutically acceptable solvates of a conessine derivative and application of fumarate or the pharmaceutically acceptable solvates to prepare acetylcholinesterase inhibitor medicaments.

The invention relates to narciprimine and fumarate of narciprimine derivative or pharmaceutically acceptable solvan as well as application in preparing medicaments for treating cancers.

The present invention relates to fumarates of 14-hydroxyantofine and 14-hydroxyantofine derivatives or pharmaceutically acceptable solvates thereof, and an application of the fumarates or the solvates in preparation of drugs for treating cancer.

The invention relates to applications of fumarates of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholine-4-yl-methyl-phenyl)-isoxazole-3-ethylformamide and derivatives thereof, or pharmaceutically acceptable solvates in the preparation of medicines for treating cancers.